Abaxis Stock Analysis (NASDAQ:ABAX)

Add to My Stocks
$48.08 $0.01 (0.02%) ABAX stock closing price Mar 24, 2017 (Closing)
Watch Robo Advisor Video of ABAX Stock Analysis
Abaxis
Updated on : Mar 24, 2017
previous close
ABAX 48.1 (0%)
S&P 500 2344 (0%)
Closing Price On: Mar 24, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical Products
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q3
$million
%
YOY GROWTH
Compared to the industry
Long Term Growth
5 Year CAGR:
8.3%
Operating Profit
Operating Margin:
20.2%
Sector Average:
-6.4%
5 Quarter Net Profit
Net Margins
2017-Q3
%
LTM Margin
Compared to the industry
Debt/Equity Ratio
Debt:
0.3M
Debt/Equity Ratio:
 0
Compared to the industry
Cash Flow
Operating cash flow:
$5.5M
Net Income:
$6.8M
Dividend Yield
ABAX dividend yield:
1.02%
PROS      CONS
Operating Margins
Net Margins
Low Debt Burden
ROIC
ROE
FCF Margin
Recent Growth
Long Term Growth
PE Valuation
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
ABAX PS :
4.8
Industry PS :
4.7
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
26%
Return on Equity:
13.8%
Free Cash Flow Margin:
6%
Double Tap To Exit Full Screen
0:00
/

Abaxis Analysis Video

55 5 2

View Abaxis stock analysis video. This is our ABAX analyst opinion covering the buy and sell arguments for ABAX stock.

Abaxis Inc Stock Rating (3.6/5)

Our Abaxis stock opinion is based on fundamentals of the company. This Abaxis stock analysis is based on latest Q3 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.

Should you buy ABAX stock?

  • Abaxis's average operating margin of 20.2% was exceptional.
  • Net margins came in at average 15.1% for Abaxis over the last twelve months.
  • With a debt/equity ratio of  0, Abaxis is comparatively less leveraged than its peers in the Medical sector.
  • Abaxis's return on invested capital of 26% is good.
  • The LTM ROE of 13.8% for Abaxis is attractive.
  • Abaxis has a healthy FCF (Free Cash Flow) margin of 6%.

Should you sell ABAX stock?

  • Abaxis sales declined by -0.2% year on year in 2017 Q3.
  • Long term revenue growth of 8.3% over the past 5 years has been disappointing.
  • The ABAX stock currently trades at a PE of 37, which is expensive, compared to the industry average of 21.

Comments on this video and Abaxis stock